rxstat › Shortages › Nadroparin

Nadroparin shortage status

Widespread shortage

Source: Health Canada shortage reports · Updated Jul 9, 2026

Nadroparin is in a widespread shortage in Canada. 7 of 8 reported products are affected. Manufacturers have not committed to a recovery date.
Products affected
7 / 8
In shortage since
Oct 29, 2020
Reports on file
10
Talk to your pharmacist. Pharmacists can often substitute another manufacturer's version, a different strength, or (in most provinces) adapt or renew a prescription on the spot. Your free provincial health line is 811.

Reports by product

Active shortage
FRAXIPARINE
9500UNIT · SOLUTION · ASPEN PHARMACARE CANADA INC.
DIN 02450631 · since ?, no end estimate · Delay in shipping of the drug.
Active shortage
FRAXIPARINE
9500UNIT · SOLUTION · ASPEN PHARMACARE CANADA INC.
DIN 02450623 · since ?, no end estimate · Delay in shipping of the drug.
Active shortage
FRAXIPARINE
9500UNIT · SOLUTION · ASPEN PHARMACARE CANADA INC.
DIN 02236913 · since ?, no end estimate · Delay in shipping of the drug.
Active shortage
FRAXIPARINE
9500UNIT · SOLUTION · ASPEN PHARMACARE CANADA INC.
DIN 02450658 · since ?, no end estimate · Disruption of the manufacture of the drug.
Active shortage
FRAXIPARINE FORTE
19000UNIT · SOLUTION · ASPEN PHARMACARE CANADA INC.
DIN 02450674 · since Dec 4, 2020, no end estimate · Other (Please describe in comments)
Active shortage
FRAXIPARINE FORTE
19000UNIT · SOLUTION · ASPEN PHARMACARE CANADA INC.
DIN 02450666 · since Nov 2, 2020, no end estimate · Other (Please describe in comments)
Active shortage
FRAXIPARINE FORTE
19000UNIT · SOLUTION · ASPEN PHARMACARE CANADA INC.
DIN 02240114 · since Oct 29, 2020, no end estimate · Other (Please describe in comments)
Resolved
FRAXIPARINE
9500UNIT · SOLUTION · ASPEN PHARMACARE CANADA INC.
DIN 02450631 · ended Apr 26, 2021 · Delay in shipping of the drug.
Resolved
FRAXIPARINE
9500UNIT · SOLUTION · ASPEN PHARMACARE CANADA INC.
DIN 02450631 · ended May 7, 2020 · Delay in shipping of the drug.
Resolved
FRAXIPARINE
9500UNIT · SOLUTION · ASPEN PHARMACARE CANADA INC.
DIN 02450615 · ended Jan 2, 2014 · Other (Please describe in comments)

What's happening

Nadroparin is currently affected by 7 active shortage reports filed with Health Canada by ASPEN PHARMACARE CANADA INC..

The reported causes are: delay in shipping of the drug; disruption of the manufacture of the drug; other (please describe in comments). Manufacturers must report shortages, but end-date estimates are their own projections and often move.

If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.

Nadroparin is classified under “ANTITHROMBOTIC AGENTS” (ATC B01AB).

Recent changes

Common questions

When will Nadroparin be back in stock in Canada?

Manufacturers have not provided a reliable end date. This page updates automatically as soon as an estimate is filed.

Why is Nadroparin in shortage?

See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Related drugs (antithrombotic agents)

Widespread shortageTicagrelor2 of 4 reported products affected · est. return Jul 31, 2026Partial shortageBivalirudin1 of 3 reported products affected · est. return Jun 30, 2026Partial shortageClopidogrel4 of 18 reported products affected · est. return Nov 10, 2026Partial shortageDabigatran Etexilate2 of 6 reported products affected · est. return Jun 12, 2026Partial shortageEdoxaban1 of 6 reported products affected · est. return Jul 10, 2026Partial shortageRivaroxaban5 of 18 reported products affected · est. return Nov 30, 2026

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.